![]() |
![]() Ana Mrejeru B.S., Loyola University of Chicago email: ana1 at uchicago dot edu Advisor: Nino Ramirez |
|
Our
daily
movements and habits rely on midbrain dopamine (DA) release. This is
because DA
cells are intricately connected to sensorimotor regions throughout the
brain,
including the basal ganglia, hippocampus, amygdala, and frontal cortex.
Many
excitatory and inhibitory inputs converge onto the DA cells, which must
integrate this information. Therefore, the intrinsic excitability of
single DA
neurons is critical for information processing. My project explores how
the DA
neuron amplifies or dampens synaptic inputs, and which membrane
channels
determine the responsiveness to input. Slice physiology and
pharmacology are combined
to manipulate single DA cells in the Substantia nigra, and molecular
techniques
(immunofluorescence, single-cell RT-PCR and knock-out mice) are used to
confirm
the expression of particular ion channels. I hypothesize that a
recently
characterized TRPM4 channel boosts phasic dopamine release and that
several
potassium channels regulate the timing of release. This study will
demonstrate a
calcium-dependent burst firing mechanism that may have implications for
the
selective vulnerability of DA neurons to cell death. In addition, the
amount of
DA released at post-synaptic targets, such as the striatum and
prefrontal
cortex, ultimately affects action selection in goal-directed behaviors.
Inappropriate
amounts of DA in the brain cause various psychiatric disorders of
motivation
and reward-learning, including Major Depression, Attention-deficit
Hyperactivity Disorder (ADHD), Schizophrenia, and drug addiction.
Furthermore,
the loss of DA cells is Parkinson’s disease (PD) affects millions of
people by
impairing the ability to walk, talk, and complete simple tasks. Current
L-DOPA
therapy increases DA levels, but often to excess, causing unwanted and
disordered movements. Thus, the ability to fine-tune the amount of DA
release
by targeting intrinsic membrane properties may help restore coordinated
movement in these patients. |
|
Committee on Neurobiology | University of Chicago |
| 04/09/08 |